Skip to main content

Advertisement

Log in

Ursodeoxycholic Acid in the Prevention of Gallstone Formation after Bariatric Surgery: A Meta-analysis

  • Other
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

Rapid weight loss increases risk for gallstone formation. Prophylactic cholecystectomy is difficult. Several small trials have shown that ursodeoxycholic acid (UDCA) may prevent gallstone formation after bariatric surgery. The aim of this study is to assess the efficacy and safety of UDCA in the prevention of gallstone formation after bariatric surgery.

Methods

Electronic databases, including the Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, Australasian Medical Index, LILACS, and HERDIN, were searched. Reference lists of trials selected by the above electronic searching were also searched. Authors of the retrieved trials and pharmaceutical companies were also contacted for other trials, published and unpublished. A meta-analysis of all randomized, double-blind, placebo-controlled prospective trials comparing UDCA and placebo was performed.

Results

Five RCTs including 521 patients were assessed. Random effects meta-analysis showed a significant reduction of gallstone formation (RR 0.43, 95% confidence interval 0.22–0.83), with 8.8% of those taking UDCA developing gallstones compared to 27.7% for placebo. Although this meta-analysis is heterogeneous with I 2 of 61.9%, the directions of the effect are all consistently in favor of UDCA (p = 0.01). A meta-analysis on the adverse effects could not be performed because the studies did not report them in a way to make the analysis possible.

Conclusions

UDCA can prevent gallstone formation after bariatric surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wudel LJ, Wright JK, Debelak JP, et al. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study. J Surg Res. 2002;102(1):50–6.

    Article  PubMed  CAS  Google Scholar 

  2. Worobetz LJ, Inglis FG, Shaffer EA. The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss. Am J Gastroenterol. 1993;88(10):1705–10.

    PubMed  CAS  Google Scholar 

  3. Miller K, Hell E, Lang B, et al. Gallstone formation prophylaxis after gastric restrictive procedures for weight loss: a randomized double-blind placebo-controlled trial. Ann Surg. 2003;238(5):697–702.

    Article  PubMed  Google Scholar 

  4. Sugerman HJ, Brewer WH, Shiffman ML, et al. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg. 1995;169:91–7.

    Article  PubMed  CAS  Google Scholar 

  5. The Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions 4.2.6. updated September 2006.

  6. Williams CN, Gowan R, Perey BJ. A double-blind placebo-controlled trial of ursodeoxycholic acid in the prevention of gallstones during weight loss after vertical banded gastroplasty. Obes Surg. 1993;3:257–9.

    Article  PubMed  Google Scholar 

  7. Taylor J, Leitman M, Horowitz M. Is routine cholecystectomy necessary at the time of roux-en-y gastric bypass? Obes Surg. 2006;16:759–61.

    Article  PubMed  Google Scholar 

  8. Fuller W, Rasmussen JJ, Ghosh J, Ali MR. Is routine cholecystectomy indicated for asymptomatic cholelithiasis in patients undergoing gastric bypass? Obes Surg. 2007;17:747–51.

    Article  PubMed  Google Scholar 

  9. Scott DJ, Villegas L, Sims TL, Hamilton EC, Provost DA, Jones DB. Intraoperative ultrasound and prophylactic ursodiol for gallstone prevention following laparoscopic gastric bypass. Surg Endosc. 2003;17:1796–802.

    Article  PubMed  CAS  Google Scholar 

  10. Shiffman ML, Kaplan GD, Brinkman-Kaplan V, et al. Prophylaxis against gallstone formation with ursodeoxycholic acid in patients participating in a very-low-calorie diet program. Ann Int Med. 1995;122(12):899–905.

    PubMed  CAS  Google Scholar 

  11. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. J Am Med Assoc. 2004;292(14):1724–37.

    Article  CAS  Google Scholar 

  12. Broomfield PH, Chopra R, Sheinbaum RC, et al. Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight. N Engl J Med. 1998;319(24):1567–72.

    Google Scholar 

  13. Lafferrere B, Heshka S, Wang K, et al. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care. 2007;30:1709–16.

    Article  Google Scholar 

  14. Feldman M, Friedman LS, Brandt LJ. Sleisenger and Fordtran’s gastrointestinal and liver disease: pathophysiology/diagnosis/management. Philadelphia: Saunders Elsevier; 2006.

    Google Scholar 

  15. Tan-Tin Hay LM, Oliveros E, Esguerra E, et al. A review of the metabolic profile of patients undergoing bariatric surgery in St. Luke’s Medical Center (2002–2004). Philipp J Int Med. 2005;43:323–30.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Manley C. Uy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Uy, M.C., Talingdan-Te, M.C., Espinosa, W.Z. et al. Ursodeoxycholic Acid in the Prevention of Gallstone Formation after Bariatric Surgery: A Meta-analysis. OBES SURG 18, 1532–1538 (2008). https://doi.org/10.1007/s11695-008-9587-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-008-9587-7

Keyword

Navigation